-
Bortezomib (PS-341, SKU A2614): Reliable Proteasome Inhib...
2026-01-21
This article delivers actionable, scenario-driven guidance for leveraging Bortezomib (PS-341) (SKU A2614) in cell viability, cytotoxicity, and apoptosis assays. Drawing on peer-reviewed data and real laboratory challenges, we demonstrate how APExBIO's Bortezomib streamlines workflows, enhances reproducibility, and provides robust experimental control for proteasome-regulated cellular process research.
-
Carboplatin: Platinum-Based DNA Synthesis Inhibitor for C...
2026-01-20
Carboplatin is a rigorously validated platinum-based DNA synthesis inhibitor for cancer research. It demonstrates robust, quantifiable antiproliferative effects in ovarian and lung carcinoma models and is widely used for benchmarking DNA damage response and repair inhibition. This article details its mechanism, experimental benchmarks, and integration parameters for preclinical oncology workflows.